ES557626A0 - Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos - Google Patents

Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos

Info

Publication number
ES557626A0
ES557626A0 ES557626A ES557626A ES557626A0 ES 557626 A0 ES557626 A0 ES 557626A0 ES 557626 A ES557626 A ES 557626A ES 557626 A ES557626 A ES 557626A ES 557626 A0 ES557626 A0 ES 557626A0
Authority
ES
Spain
Prior art keywords
diphenilices
procedure
new derivatives
prepare new
nitrile esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557626A
Other languages
English (en)
Other versions
ES8802491A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Laboratoires Hoechst SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Hoechst SA filed Critical Laboratoires Hoechst SA
Publication of ES557626A0 publication Critical patent/ES557626A0/es
Publication of ES8802491A1 publication Critical patent/ES8802491A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES557626A 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos Expired ES8802491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8505123A FR2587339B1 (fr) 1985-04-04 1985-04-04 Nouveaux medicaments constitues par des derives-2,3 ou -3,4 diphenyles des esters g-nitriles ou leurs produits de cyclisation et procedes pour les preparer

Publications (2)

Publication Number Publication Date
ES557626A0 true ES557626A0 (es) 1988-07-01
ES8802491A1 ES8802491A1 (es) 1988-07-01

Family

ID=9317941

Family Applications (4)

Application Number Title Priority Date Filing Date
ES553642A Expired ES8802219A1 (es) 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.
ES557625A Expired ES8802490A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos
ES557626A Expired ES8802491A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES557801A Expired ES8802221A1 (es) 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES553642A Expired ES8802219A1 (es) 1985-04-04 1986-04-02 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres de p-nitrilos.
ES557625A Expired ES8802490A1 (es) 1985-04-04 1987-07-16 Procedimiento para preparar nuevos derivados 2,3-difenilicos de esteres -8-nitrilos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557801A Expired ES8802221A1 (es) 1985-04-04 1988-01-15 Procedimiento para ciclizar derivados 2,3-difenilicos de esteres-j-nitrilos

Country Status (11)

Country Link
US (1) US4785007A (es)
EP (1) EP0203308A2 (es)
JP (1) JPS61229854A (es)
KR (1) KR860008139A (es)
AU (1) AU5561786A (es)
DK (1) DK151586A (es)
ES (4) ES8802219A1 (es)
FR (1) FR2587339B1 (es)
GR (1) GR860891B (es)
PT (1) PT82333B (es)
ZA (1) ZA862458B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI875101A (fi) * 1986-12-03 1988-06-04 Tanabe Seiyaku Co Laktamderivat och preparat innehaollande dessa.
JP4943429B2 (ja) * 2005-07-22 2012-05-30 メルク・シャープ・エンド・ドーム・コーポレイション カリウムチャネル阻害剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE765203C (de) * 1939-08-02 1953-06-01 Ig Farbenindustrie Ag Verfahren zur Herstellung von Piperidonen und Piperidinen
US3468893A (en) * 1966-03-14 1969-09-23 Ciba Geigy Corp 1-substituted-diphenyl-azacycloalkenes
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
US3814771A (en) * 1970-11-19 1974-06-04 T Shen 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones
US3718743A (en) * 1970-11-19 1973-02-27 Merck & Co Inc 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams

Also Published As

Publication number Publication date
GR860891B (en) 1986-08-04
ES8802219A1 (es) 1988-04-16
ES557625A0 (es) 1988-07-01
ES557801A0 (es) 1988-04-16
ES8802221A1 (es) 1988-04-16
ES553642A0 (es) 1988-04-16
KR860008139A (ko) 1986-11-12
DK151586A (da) 1986-10-05
JPS61229854A (ja) 1986-10-14
FR2587339B1 (fr) 1988-08-05
PT82333A (fr) 1986-05-01
US4785007A (en) 1988-11-15
ZA862458B (en) 1986-11-26
FR2587339A1 (fr) 1987-03-20
ES8802491A1 (es) 1988-07-01
EP0203308A2 (de) 1986-12-03
AU5561786A (en) 1986-10-09
PT82333B (fr) 1988-04-07
ES8802490A1 (es) 1988-07-01
DK151586D0 (da) 1986-04-03

Similar Documents

Publication Publication Date Title
ES550692A0 (es) Procedimiento para preparar nuevas somatostatinas
ES557240A0 (es) Procedimiento para preparar nuevos 2-arilimidazoles
AR240830A1 (es) Procedimiento para preparar derivados de acidos naftiridin quinolin-y benzoxazincarboxilicos.
MX162864B (es) Procedimiento para la preparacion de 2,2,6,6-tetraalquil-4-piperidilaminas
ES556370A0 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
ES551439A0 (es) Procedimiento para preparar 4h-1-benzopiran-4-onas
ES556974A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES550240A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES551069A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbenicina
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES557692A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES557728A0 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
ES549804A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES543524A0 (es) Procedimiento para preparar benzoxazolil- y benzotiazolil- aminoacidos
DK281886D0 (da) Glycerinderivater
ES554092A0 (es) Procedimiento para la obtencion de viniciclopropancarboxilatos
ES548235A0 (es) Procedimiento para preparar n6-benzopirano- y benzotiopira- no-adenosinas
ES557313A0 (es) Procedimiento para preparar derivados de fenilpirazina
ES556878A0 (es) Procedimiento para la obtencion de 3-acilaminobenzisotiazol-s,s-dioxidos
ES557626A0 (es) Procedimiento para preparar nuevos derivados 3,4-difenilicos de esteres -8-nitrilos
ES549378A0 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES546558A0 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
ES554312A0 (es) Procedimiento para preparar 5(4h)-isoxazolonas
ES555036A0 (es) Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina
ES554339A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina